Oxford Immunotec Global PLC Announces Pricing Of Initial Public Offering

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OXFORD, England & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Oxford Immunotec Global PLC (NASDAQ: OXFD) (the "Company") announced today that its initial public offering of 5,360,000 ordinary shares priced at $12.00 per share. The Company has granted the underwriters the option to purchase up to an additional 804,000 ordinary shares at the initial public offering price less the underwriting discount. The ordinary shares are expected to begin trading on The NASDAQ Global Market on November 22, 2013 under the trading symbol "OXFD."

Help employers find you! Check out all the jobs and post your resume.

Back to news